21
Nile Pharmaceuticals & Chemical Industries (NIPH.CA) reported a net profit of EGP 25.310 million during the first half of 2012, 47% down from a year earlier net profit of EGP 48 million.
Worth mentioning, Nile Pharmaceuticals board of directors had ratified the company’s business results for H1/2012 which revealed that net profit available for distribution hit EGP 19.1 million, compared to EGP 45 million during H1/2011.
